Neuphoria Therapeutics Inc. Adjustments For Decrease Increase In Trade Account Receivable
Neuphoria Therapeutics Inc. (NEUP) reported Adjustments For Decrease Increase In Trade Account Receivable of AUD 49.64 thousand for the 12-month period ending 2023-06-30, per its 20-F filed 2023-10-18.
Discontinued › Notes › Receivables
ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2023-10-18
| Period end | Adjustments For Decrease Increase In Trade Account Receivable 12 month |
|---|---|
| 2023-06-30 | 49.64K AUD 20-F · filed 2023-10-18 |
| 2022-06-30 | -39.15K AUD 20-F · filed 2023-10-18 |
| 2021-06-30 | 34.08K AUD 20-F · filed 2023-10-18 |
| 2020-06-30 | -202.26K AUD 20-F · filed 2022-10-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |